معرفی
Dr. Mohamed Kahila is an Assistant Professor of Pathology at Yale University's Yale School of Medicine, specializing in breast and molecular genetics pathology. He practices at Yale New Haven Hospital and Smilow Cancer Hospital/Yale Cancer Center, contributing to multidisciplinary cancer care.
Education & Training:
- MBBCh (Medical Degree) from Ain Shams University, Egypt
- Research Fellowship: Mayo Clinic Rochester (DNA repair inhibitors in breast cancer)
- Anatomic/Clinical Pathology Residency: SUNY Downstate Medical Center
- Breast Pathology Fellowship: Brigham and Women’s Hospital
- Molecular Genetic Pathology Fellowship: Yale New Haven Hospital
Research Focus: Dr. Kahila's work centers on breast cancer biology, DNA damage response mechanisms, and translational research in immunotherapy and radiation oncology. He collaborates on international initiatives like the International Immuno-Oncology Biomarker Working Group, advancing tumor immune profiling and machine learning applications in pathology.
Publications: His recent work includes critical analyses of tumor-infiltrating lymphocyte assessment via machine learning and spatial immune profiling in cancer. He has also investigated radiosensitizing strategies (ATR inhibition) and PD-L1's role in DNA damage pathways.
Professional Involvement: Active in clinical care and academic pathology, Dr. Kahila contributes to optimizing proton therapy protocols and minimizing treatment toxicities. He maintains affiliations with Yale's Breast Pathology division and Molecular Genetic Pathology services.